Mucus and Mucins

Otolaryngologic Clinics of North America

Volumn 43, Issue 1, 2010, Pages 27-34

  Rubin, Bruce K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cough; Mucins; Mucus; Phlegm; Rheology; Sputum; Tenacity

Indexed keywords

BRONCHODILATING AGENT; DORNASE ALFA; EXPECTORANT AGENT; MACROLIDE; MUCIN; MUCIN 2; MUCIN 5B; MUCIN 7; MUCOLYTIC AGENT; THYMOSIN BETA4;

BRONCHIECTASIS; CHRONIC BRONCHITIS; CYSTIC FIBROSIS; DNA CONTENT; HUMAN; LOWER RESPIRATORY TRACT; MUCOCILIARY CLEARANCE; MUCOCILIARY TRANSPORT; MUCOLYSIS; MUCUS; MUCUS SECRETION; REVIEW; UPPER RESPIRATORY TRACT OBSTRUCTION; VISCOELASTICITY;

COUGH; EXPECTORANTS; HUMANS; LUNG DISEASES; MUCINS; MUCUS; RHEOLOGY;

EID: 76749085784     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2009.11.002     Document Type: Review

References (37)

1. Voynow J.A., and Rubin B.K. Mucus, mucins, and sputum. Chest 135 (2009) 505-512
2. Thomas B., Rutman A., and O'Callaghan C. Disrupted ciliated epithelium shows slower ciliary beat frequency and increased dyskinesia. Eur Respir J 34 (2009) 401-404
3. Rubin B.K. Mucus, phlegm, and sputum in cystic fibrosis. Respir Care 54 (2009) 726-732
4. Thornton D.J., Rousseau K., and McGuckin M.A. Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol 70 (2008) 459-486
5. Sharma P., Dudus L., Nielsen P.A., et al. MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways. Am J Respir Cell Mol Biol 19 (1998) 30-37
6. Sheehan J.K., Richardson P.S., Fung D.C., et al. Analysis of respiratory mucus glycoproteins in asthma: a detailed study from a patient who died in status asthmaticus. Am J Respir Cell Mol Biol 13 (1995) 748-756
7. Davies J.R., Kirkham S., Svitacheva N., et al. MUC16 is produced in tracheal surface epithelium and submucosal glands and is present in secretions from normal human airway and cultured bronchial epithelial cells. Int J Biochem Cell Biol 39 (2007) 1943-1954
8. Matsui H., Randell S.H., Peretti S.W., et al. Coordinated clearance of periciliary liquid and mucus from airway surfaces. J Clin Invest 102 (1998) 1125-1131
9. Rubin B.K., Fink J.B., and Henke M.O. Mucus-controlling drug therapy. In: Doug G. (Ed). Rau's respiratory care pharmacology. 7th edition (2008), Elsevier Press, Philadelphia (PA) 162-190
10. King M., and Rubin B.K. Mucus rheology, relationship with transport. In: Takishima T. (Ed). Airway secretion: physiological bases for the control of mucus hypersecretion (1994), Marcel Dekker, Inc, New York 283-314 chapter 7
11. Basser P.J., McMahon T.A., and Griffith P. The mechanism of mucus clearance in cough. J Biomech Eng 111 (1989) 288-297
12. Hassan A.A., Evrensel C.A., and Krumpe P.E. Clearance of viscoelastic mucus simulant with airflow in a rectangular channel, an experimental study. Technol Health Care 14 (2006) 1-11
13. Albers G.M., Tomkiewicz R.P., May M.K., et al. Ring distraction technique for measuring surface tension of sputum: relationship to sputum clearability. J Appl Phys 81 (1996) 2690-2695
14. Rubin B.K. Surface properties of respiratory secretions: relationship to mucus transport. In: Baum G. (Ed). Cilia, mucus, and mucociliary interactions (1998), Marcel Dekker, Inc, New York 317-324 chapter 32
15. Clunes M.T., and Boucher R.C. Front-runners for pharmacotherapeutic correction of the airway ion transport defect in cystic fibrosis. Curr Opin Pharmacol 8 (2008) 292-299
16. Burgel P.R., and Nadel J.A. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 59 (2004) 992-996
17. Kishioka C., Okamoto K., Kim J.-S., and Rubin B.K. Hyperosmolar solutions stimulate mucus secretion in the ferret trachea. Chest 124 (2003) 306-313
18. Katz I., Zwas T., Baum G.L., et al. Ciliary beat frequency and mucociliary clearance. What is the relationship?. Chest 92 (1987) 491-493
19. Bush A., Payne D., Pike S., et al. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis. Chest 129 (2006) 118-123
20. Rubin B.K. Mucus structure and properties in cystic fibrosis. Paediatr Respir Rev 8 (2007) 4-7
21. Rubin B.K. Designing clinical trials to evaluate mucus clearance therapy. Respir Care 52 (2007) 1348-1361
22. Ragavan AJ, Evrensel CA, Krumpe P. Interactions of airflow oscillation, tracheal inclination, and elasticity significantly improve mucus clearance during simulated cough. Chest, in press. PMID:19762551.
23. Allegra L., Bossi R., and Braga P. Influence of surfactant on mucociliary transport. Eur J Respir Dis Suppl 142 (1985) 71-76
24. Anzueto A., Jubran A., Ohar J.A., et al. Effects of aerosolized surfactant in patients with stable chronic bronchitis. A prospective randomized controlled trial. JAMA 278 (1997) 1426-1431
25. Kim J.-S., and Rubin B.K. Nasal and sinus involvement in chronic obstructive pulmonary disease. Curr Opin Pulm Med 14 (2008) 101-104
26. Robertson J.M., Friedman E.M., and Rubin B.K. Nasal and sinus disease in cystic fibrosis. Paediatr Respir Rev 9 (2008) 213-219
27. Rubin B.K., Tomkiewicz R.P., and King M. Mucoactive agents: old and new. In: Wilmott R.W. (Ed). The pediatric lung (1997), Birkhäuser Publishing, Ltd, Basel (Switzerland) 155-179 chapter 7
28. Henke M.O., Renner A., Huber R.M., et al. MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am J Respir Cell Mol Biol 31 (2004) 86-91
29. Rubin B.K. Who will benefit from DNase?. Pediatr Pulmonol 27 (1999) 3-4
30. Kater A., Henke M.O., and Rubin B.K. The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4. Ann N Y Acad Sci 1112 (2007) 140-153
31. Rubin B.K. Mucolytics, expectorants, and mucokinetic medications. Respir Care 52 (2007) 859-865
32. Donaldson S.H., Bennett W.D., Zeman K.L., et al. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 354 (2006) 241-250
33. Daviskas E., Anderson S.D., Gomes K., et al. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum. Respirology 10 (2005) 46-56
34. Henke M.O., Gerrit J., Germann M., et al. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during a pulmonary exacerbation. Am J Respir Crit Care Med 175 (2007) 816-821
35. Zayas G., Valle J.C., Alonso M., et al. A new paradigm in respiratory hygiene: modulating respiratory secretions to contain cough bioaerosol without affecting mucus clearance. BMC Pulm Med 13 7 (2007) 11
36. Shinkai M., López-Boado Y., and Rubin B.K. Clarithromycin has an immunomodulatory effect on ERK-mediated inflammation induced by P. aeruginosa flagellin. J Antimicrob Chemother 59 (2007) 1096-1101
37. Kishioka C., Okamoto K., Kim J.S., et al. Regulation of secretion from mucous and serous cells in the excised ferret trachea. Respir Physiol 126 (2001) 163-171